Recombinant Monoclonal Human anti-Human CD22 Antibody (clone hL22 (Epratuzumab), CD22) LS-C777525

Catalog Number: LS-C777525-0.2
Article Name: Recombinant Monoclonal Human anti-Human CD22 Antibody (clone hL22 (Epratuzumab), CD22) LS-C777525
Biozol Catalog Number: LS-C777525-0.2
Supplier Catalog Number: LS-C777525-0.2
Alternative Catalog Number: LS-C777525-0.2
Manufacturer: LifeSpan Biosciences
Host: Human
Category: Antikörper
Application: Blocking, FC, IP
Species Reactivity: Human, Monkey
Immunogen: This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5-10% of the molecule, with the remainder being human framework sequences, which greatly reduces
Conjugation: Unconjugated
Alternative Names: CD22, CD22 molecule, CD22 antigen, SIGLEC2, SIGLEC-2, T-cell surface antigen Leu-14, B-cell receptor CD22, BL-CAM
This CD22 antibody is an unconjugated Human/Human chimeric recombinant monoclonal antibody. Validated for Block, Flo, and IP.
Clonality: Monoclonal
Concentration: 1 mg/ml
Clone Designation: [hL22 Epratuzumab]
NCBI: 933
Buffer: PBS, 0.02% ProClin(TM) 300.
Purity: Protein A purified
Form: PBS, 0.02% ProClin(TM) 300.
Application Dilute: Block, Flo, IP
Application Notes: Applications should be user optimized.